000 01466 a2200433 4500
005 20250513160438.0
264 0 _c19990315
008 199903s 0 0 eng d
022 _a0275-004X
024 7 _a10.1097/00006982-199806000-00017
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMargo, C E
245 0 0 _aCytomegalovirus retinitis and the lupus anticoagulant syndrome.
_h[electronic resource]
260 _bRetina (Philadelphia, Pa.)
_c1998
300 _a568-70 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAntiviral Agents
_xtherapeutic use
650 0 4 _aBiopsy
650 0 4 _aCytomegalovirus
_xgenetics
650 0 4 _aCytomegalovirus Retinitis
_xcomplications
650 0 4 _aDNA, Viral
_xanalysis
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFollow-Up Studies
650 0 4 _aGlucocorticoids
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLaser Therapy
650 0 4 _aLupus Coagulation Inhibitor
_xblood
650 0 4 _aLupus Erythematosus, Systemic
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetina
_xpathology
650 0 4 _aRetinal Hemorrhage
_xdiagnosis
650 0 4 _aSyndrome
650 0 4 _aVitrectomy
650 0 4 _aVitreous Body
_xpathology
700 1 _aArango, J L
773 0 _tRetina (Philadelphia, Pa.)
_gvol. 18
_gno. 6
_gp. 568-70
856 4 0 _uhttps://doi.org/10.1097/00006982-199806000-00017
_zAvailable from publisher's website
999 _c9832156
_d9832156